Pulmonary Nocardiosis Caused by Nocardia exalbida in a Patient with Lung Cancer and Radiation Pneumonitis: A Case Report and Literature Review

Intern Med. 2019 Jun 1;58(11):1605-1611. doi: 10.2169/internalmedicine.2177-18. Epub 2019 Feb 1.

Abstract

We report a case of Nocardia exalbida (N.exalbida)-induced pneumonia in a 70-year old Japanese man with lung cancer and radiation pneumonitis. He initially received doripenem (1.5 g/day) for pneumonia treatment, and N.exalbida was identified by a clone library analysis of bronchoalveolar lavage fluid obtained from the pneumonia lesion. The doripenem dosage was therefore increased to 3.0 g/day with adjunctive trimethoprim/sulfamethoxazole, and his pneumonia improved. N. exalbida is susceptible to antibiotics; thus, in nocardiosis, N. exalbida infection might be associated with a good response to treatment, although its clinical findings are non-specific and similar to those of other Nocardia infections.

Keywords: lung cancer; nocardia; pulmonary nocardiosis; radiation pneumonitis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Doripenem / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Lung Neoplasms / complications*
  • Male
  • Nocardia / classification
  • Nocardia / isolation & purification*
  • Nocardia Infections / complications*
  • Nocardia Infections / drug therapy
  • Nocardia Infections / microbiology
  • Opportunistic Infections / complications*
  • Opportunistic Infections / drug therapy
  • Radiation Pneumonitis / complications*
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Doripenem